Degenerative cervical myelopathy (DCM) (historically termed “cervical spondylotic myelopathy” [CSM]) is the most common non-traumatic, progressive spinal cord disorder with an estimated 2% prevalence [1]. The disorder is indeed imprecisely and insufficiently characterized by neck and radicular pain, fine motor dysfunction, gait instability, and bladder dysfunction and for most lacks common diagnostic criteria [2]. If not recognized and treated timely, patients may eventually present as incomplete cervical spinal cord injury (SCI). This letter aims to raise awareness of these shortcomings in the neurological community and emphasize an ongoing initiative to improve clinical care and foster global research [3]. The neurological field should not be left out in this effort.

Due to a variety of symptoms, patients eventually get referred to different specialists, commonly orthopedics, neurosurgeons, neurologists, or physiotherapists. While surgical decompression of the encroached spinal cord is recommended in patients experiencing already moderate/severe, or progressive symptoms, the goal of enabling earlier and/or preventative treatment has now been defined as a priority research need. In its early stages, DCM is frequently underdiagnosed or misdiagnosed as carpal tunnel syndrome or peripheral neuropathy, until patients develop more severe impairments of upper and lower limb function urging the consideration of incomplete cervical SCI. Given that DCM is a progressive but preventable neurological condition, the delayed diagnosis and late referral for evaluation of surgical decompression, can lead to poorer neurological outcomes [4]. In addition, the pre-operative neurological status significantly influences post-operative recovery [5]. Therefore, an early diagnosis is important to achieve good clinical results. The diagnosis of DCM is currently based on clinical signs and symptoms, eventually complemented by cervical spine MRI. However, there is still no consensus on diagnostic criteria for DCM, leading to ambiguous, descriptive clinical diagnoses, and heterogenous definitions of DCM applied in clinical studies [6, 7]. Furthermore, as demonstrated in the UK, DCM is rarely covered in the medical curriculum [8]. AO Spine RECODE-DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy) (aospine.org/recode) is an international, interdisciplinary, and interprofessional initiative, including patients with DCM, which aims to accelerate knowledge discovery that can change outcomes [9]. This has included the formation of research priorities such as the development of common diagnostic criteria. Alongside its importance for clinical care, a sensitive and specific set of diagnostic criteria is required to foster research, particularly for those studies aiming at investigating neuroprotective strategies. Diagnostic criteria for DCM can help to overcome several shortcomings in patient care and research (Fig. 1). The development of diagnostic criteria for DCM would benefit from the experiences of the neurological community; a UK cohort study identified 45% of cases are initially diagnosed by Neurologists, whilst Neurologists are familiar with their development and implementation [10]. Common criteria will help the dialog between neurologists, general practitioners (primary care providers), and spine specialists, and propagate the knowledge of red flags in DCM that require timely and specific actions, before established SCI. The development of diagnostic criteria involves both comprehensive diagnostic criteria for research and spine specialists, as well as easily applicable algorithms that speed up referral to cervical spine MRI and spine specialists. We have established an initial working group to act upon this opportunity (AO Spine RECODE DCM Diagnostic Criteria Incubator). If you are interested in contributing to this process, please contact us.Fig. 1

The panels summarize shortcomings in patient care and research which diagnostic criteria for DCM can help to overcome.